Antibiotic treatment guidelines may favor shorter courses over full courses

Recent medical evidence suggests that the long-standing advice to always finish a full course of prescribed antibiotics may not be necessary for all bacterial infections. A review of more than 120 randomized controlled trials indicates that shorter courses can be just as effective and safe as longer durations for treating various ailments, ranging from routine urinary tract infections to pneumonia.

Contrary to the traditional belief that incomplete courses drive antibiotic resistance, researchers suggest that shorter treatments may actually decrease resistance. The theory that surviving bacteria from unfinished courses stage a comeback is described by authors in Clinical Microbiology and Infection as being based on an “urban legend.” Instead, longer exposure to antibiotics may increase the selective pressure that drives the development of drug-resistant “superbugs.”

While public health guidance since the 1940s has emphasized completing all medication, experts note that the nuance of individualized treatment is often lost in patient communication. Addressing antibiotic resistance remains a critical global priority, as drug-resistant bacteria are linked to over 1 million deaths annually.